Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ron Wyden

Chuck Schumer Urges Senators To Help Finalize Marijuana Legalization Bill He Will File In April

Senate Majority Leader Charles Schumer (D-N.Y.), Finance Committee Chairman Ron Wyden (D-Ore.) and Sen. Cory Booker (D-N.J.) asked senators to help them complete the marijuana legalization bill expected to be filed in April.

Crypto industry poised to play larger role in midterm campaigns

WASHINGTON — The 2022 elections will test whether the cryptocurrency industry, now more than five times its value in late 2020 and fired up by a tax provision enacted in November, will boost spending on political campaigns.

Tribune News Service

Senate Finance leaders outline mental health legislative timeline - Roll Call

Senate Finance leaders outline mental health legislative timeline - Roll Call

Senate Finance Committee leaders said they aim to put together a bipartisan legislative package addressing mental health.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Crypto industry poised to play larger role in midterm campaigns - Roll Call

The crypto currency industry contributed far more money to candidates in 2021 than in 2019, a sign of its growing market value.

IRS use of selfie software is ‘unacceptable’, key Democrat says

A senior Senate Democrat is urging the Internal Revenue Service to abandon the use of a facial recognition software for taxpayers to access their documents online.

Tribune News Service

Sen. Chuck Schumer To File Cannabis Legalization Bill In April, Welcomes GOP Support

Senate Majority Leader Chuck Schumer (D-N.Y.) and fellow Sens. Cory Booker (D-N.J.) and Ron Wyden (D-Ore.)

Wyden probes FDA nominee’s views on accelerated drug approvals

WASHINGTON — Senate Finance Chair Ron Wyden, D-Ore., is pressing the White House’s nominee to lead the Food and Drug Administration, Robert Califf, to pledge to crack down on drugmakers’ use of fast-track approval pathways as the nominee seeks the chairman’s support.

Tribune News Service

inkl

Read news from The Economist, FT, and more,
with one subscription

Democrats mulling revival of employee retention tax credit - Roll Call

Democrats mulling revival of employee retention tax credit - Roll Call

Senators are considering putting the employee retention tax credit back in place after retroactively cutting it off at the end of September.

Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call

Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call

Support from Wyden could be crucial to Robert Califf's FDA confirmation amid concerns from other Senate Democrats.

Democrats 'not ready to throw in the towel' on child tax credit - Roll Call

Democrats 'not ready to throw in the towel' on child tax credit - Roll Call

Top Democratic tax writers remained optimistic Thursday about restoring a more generous version of the child tax credit.

1 … 14 15 16 17

People

Charles E. Schumer

Joe Manchin III

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Republican Party

Food and Drug Administration

Internal Revenue Service

Finance Committee

Senate Finance Committee

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play